Follow the 툴젠 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 툴젠 has logged 59 public disclosures. Market capitalisation: €363.9bn. The latest transaction was disclosed on 8 July 2026 (Purchase). Among the most active insiders: 한지학. Every trade is accessible without an account.
59
Insider Decl.
n/a
Thresholds
n/a
25 ops.
Buy Volume
n/a
3 ops.
Sell Volume
21Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,407 of 28,134 companies
33.8
score / 100
Value
18
Quality
49
FCF yld-6.0%
Earn yld-11%
EV/EBITDA·
ROE-69%
Gross mgn87%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.